NCT06620575

Brief Summary

This is a single-center, retrospective, observational study based on data extracted from the medical records of patients who underwent a procedure for persistent atrial fibrillation ablation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
542

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 29, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

1.1 years

First QC Date

September 18, 2024

Last Update Submit

September 26, 2024

Conditions

Atrial Fibrillation

Outcome Measures

Primary Outcomes (1)

  • Recurrence of persistent atrial fibrillation

    The main objective of the study is to assess to what extent patient characteristics and conditions during the atrial fibrillation ablation procedure can identify predictive factors for recurrence. Recurrence (Yes/No) is the outcome variable to be explained.

    Month 12

Interventions

Atrial fibrillation ablationPROCEDURE

Persistent atrial fibrillation ablation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient who underwent a procedure for persistent atrial fibrillation ablation at Clairval Hospital since January 2014

You may qualify if:

  • Patient aged 18 years or older, who has been informed about the research
  • Patient who underwent a procedure for persistent atrial fibrillation ablation at Clairval Hospital since January 2014
  • Patient for whom data regarding the ablation procedure are available

You may not qualify if:

  • Patient under legal protection, guardianship, or conservatorship
  • Patient who has expressed opposition to the use of their medical data (by completing and returning the opt-out form provided)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Privé Clairval

Marseille, 13009, France

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2024

First Posted

October 1, 2024

Study Start

March 29, 2023

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)